ZGNX

4:12 pm Zogenix misses by $0.04, beats on revs

moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2013 Financial Results

[GlobeNewswire] – SAN DIEGO — Zogenix, Inc. , a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced it will … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

Groups urge FDA to halt launch of Zohydro pain drug

[Reuters] – A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month. The opioid drug, manufactured by Zo moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix […]

Groups urge FDA to halt launch of Zohydro pain drug

[Reuters] – A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month. The opioid drug, manufactured by Zo moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix […]

8:33 am Zogenix: Data from Zohydro ER Phase 3 clinical trial published in pain medicine demonstrates its benefit as a therapeutic option for the management of pain; The 801 efficacy study in subjects with chronic low back pain met the prima

moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

Data From Zohydro(TM) ER (hydrocodone bitartrate) Phase 3 Clinical Trial Published in Pain Medicine Demonstrates Its Benefit as a Therapeutic Option for the Management of Pain Severe Enough to Require Daily, Around-the-Clock, Long-Term Opio

[GlobeNewswire] – SAN DIEGO — Zogenix, Inc. , a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced the publication … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

Senators question FDA over hydrocodone painkiller

moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]

Zogenix Establishes External Safe-Use Board

[GlobeNewswire] – SAN DIEGO — Zogenix, Inc. , a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced the formation … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Zogenix is hiring next, click here to view […]